News
Reported Sunday, Arrowhead Pharmaceuticals Announces New Phase 2 Data Of Plozasiran Published In JAMA Cardiology And Presented At ACC.24
8 Apr 24
News
NetApp, Zoom Video And 2 Other Stocks Insiders Are Selling
4 Apr 24
News, Short Ideas, Insider Trades, Pre-Market Outlook, Markets, Trading Ideas
EQT, Genie Energy And Other Big Stocks Moving Lower On Monday
11 Mar 24
News, Penny Stocks, Small Cap, Intraday Update, Markets, Movers, Trading Ideas
Cooper Companies Reports Upbeat Results, Joins Dell, NetApp, Tidewater And Other Big Stocks Moving Higher On Friday
1 Mar 24
News, Small Cap, Intraday Update, Markets, Movers, Trading Ideas
HC Wainwright & Co. Reiterates Buy on Arrowhead Pharma, Maintains $90 Price Target
8 Feb 24
News, Price Target, Reiteration, Analyst Ratings
Citigroup Maintains Neutral on Arrowhead Pharma, Raises Price Target to $34
7 Feb 24
News, Price Target, Analyst Ratings
Cracking The Code: Understanding Analyst Reviews For Arrowhead Pharma
7 Feb 24
Analyst Ratings
RBC Capital Reiterates Outperform on Arrowhead Pharma, Maintains $50 Price Target
7 Feb 24
News, Price Target, Reiteration, Analyst Ratings
12 Health Care Stocks Moving In Tuesday's After-Market Session
6 Feb 24
Movers
Recap: Arrowhead Pharma Q1 Earnings
6 Feb 24
Earnings
Arrowhead Pharma Q1 EPS $(1.24) Misses $(0.82) Estimate, Sales $3.55M Miss $29.51M Estimate
6 Feb 24
Earnings, News
Earnings Scheduled For February 6, 2024
6 Feb 24
Earnings
Press releases
Arrowhead Pharmaceuticals Initiates Phase 1/2a Study of ARO-CFB for Treatment of Complement Mediated Kidney Disease
24 Apr 24
Press Releases
Arrowhead Pharmaceuticals Announces New Phase 2 Data of Plozasiran Published in JAMA Cardiology and Presented at American College of Cardiology 73rd Annual Scientific Session & Expo
7 Apr 24
Press Releases
Arrowhead Pharmaceuticals Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
1 Apr 24
Press Releases
Arrowhead Pharmaceuticals Initiates Expanded Access Program for Plozasiran and Announces Upcoming Presentation of Clinical Data
25 Mar 24
Press Releases
Arrowhead Pharmaceuticals Initiates Phase 1/2a Study of ARO-DM1 for Treatment of Type 1 Myotonic Dystrophy
8 Mar 24
Press Releases
Arrowhead Pharmaceuticals to Participate in Upcoming March 2024 Conferences
4 Mar 24
Press Releases
Arrowhead Pharmaceuticals Reports Fiscal 2024 First Quarter Results
6 Feb 24
Press Releases